— Know what they know.
Not Investment Advice

ZYME NASDAQ

Zymeworks Inc.
1W: +4.8% 1M: -12.0% 3M: +10.5% YTD: -5.7% 1Y: +102.0% 3Y: +178.1% 5Y: -12.2%
$25.61
+0.50 (+1.99%)
 
Weekly Expected Move ±6.9%
$21 $22 $24 $26 $27
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 36 · $1.9B mcap · 68M float · 0.983% daily turnover · Short 62% of daily vol

📊 Key Metrics

TTM
$81M
Revenue
-13.0% YoY
$-103M
Net Income
+9.7% YoY
$-45,749M
Free Cash Flow
-58159.9% YoY
-18.2%
Gross Margin
-1956.7%
Op. Margin
-1834.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-33.8%
ROA-25.4%
ROIC-155.4%

Valuation

P/E-18.6
P/B0.0
EV/EBITDA-14.9

Leverage

Debt/Equity0.07
Current Ratio5.52
Interest Cov.-52.0x

Quality Scores

Piotroski F2/9
Altman Z10.40
Beneish M-1106.80

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms